查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088790

伴侶動物術後疼痛管理治療市場：依藥物類別、動物種類、給藥途徑、手術類型、最終用戶和分銷管道分類－2026-2032年全球市場預測

Companion Animal Postoperative Pain Management Therapeutics Market by Drug Class, Animal Type, Route Of Administration, Surgery Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，伴侶動物術後疼痛管理療法的市場規模將成長至 3.2845 億美元，複合年成長率為 10.36%。

主要市場統計數據
基準年 2025 1.6465億美元
預計年份：2026年 1.8638億美元
預測年份 2032 3.2845億美元
複合年成長率 (%) 10.36%

伴侶動物術後疼痛管理正從單純的輔助治療轉變為獸醫的核心治療標準。絕育、整形外科、牙科、腫瘤科、傷口修復和微創手術數量的不斷增加，使得犬、貓和其他伴侶動物對安全有效的鎮痛藥、多模態鎮痛方案以及便捷的疼痛評估工具的需求持續成長。

這一市場趨勢受到實證獸醫指南、寵物日益「人性化」、已開發國家寵物保險普及以及美國FDA獸藥中心、加拿大衛生署、歐洲藥品管理局和各國獸醫主管部門等機構法律規範的影響。當獸醫能夠制定針對特異性物種、並根據個別動物情況量身定做的術後疼痛管理方案時，市場需求最為旺盛。此方案需結合非類固醇消炎劑、鴉片類藥物、局部麻醉劑、α2腎上腺素受體促效劑、輔助藥物、非藥物復健支持。

術後疼痛管理領域的變革性變化

目前，鎮痛治療正朝著多方面綜合的方向發展，獸醫們擴大將抗發炎治療、局部麻醉、局部麻醉劑給藥和補救鎮痛相結合，而不是依賴單一療法。美國動物醫院協會 (AAHA)、美國獸醫家庭醫師學會 (AAFP)、世界小動物獸醫協會 (WSAVA) 和其他獸醫組織都支持這種轉變，他們強調定期疼痛評分、預防性鎮痛、維持患者體溫、以舒適為導向的護理以及在整個恢復過程中進行重新評估。

人工智慧對疼痛管理的累積影響

人工智慧（AI）正透過決策支援、基於影像和影片的行為分析、遠端監測以及藥物安全監測，開始影響伴侶動物的術後疼痛管理。人工智慧系統可以幫助檢測姿勢、活動能力、食慾、叫聲、睡眠、活動量以及傷口癒合情況的變化，這些變化可能表明術後疼痛管理不足，尤其是在寵物居家復健期間。

全球獸醫疼痛管理市場關鍵區域洞察

北美地區憑藉其先進的獸醫基礎設施、較高的寵物擁有率、大量的手術量以及寵物保險的覆蓋，仍然是一個高價值市場。美國和加拿大受益於完善的FDA和加拿大衛生署核准流程、專業的醫院網路、獸醫繼續教育以及多方位鎮痛療法的廣泛應用。在拉丁美洲，隨著巴西和墨西哥對伴侶動物照護的投資，市場正在擴張，但經濟負擔、診所就診機會的差異以及分銷基礎設施的不均衡仍然影響著治療方案的推廣應用。

歐盟、七國集團、金磚國家、東協、海灣合作理事會和北約市場的關鍵群體分析

由於歐盟在藥品法規、動物福利政策、藥品安全監測要求以及獸醫專業標準方面實現了協調統一，因此已成為伴侶動物術後疼痛管理療法的監管和臨床標竿。七國集團市場擁有先進的轉診醫院、較高的可支配收入、對伴侶動物保險的認知以及完善的獸藥配銷通路，共同構成了一個卓越的獸醫創新環境。

各國對伴侶動物術後疼痛照護的深入了解

美國在產品供應、專業護理的引入、繼續教育以及術後疼痛管理方案的標準化方面處於主導地位。另一方面，加拿大受益於健全的獸醫管治、較高的寵物健康意識以及不斷成長的寵物保險普及率。墨西哥和巴西是拉丁美洲的主要成長市場，其中巴西以其龐大的寵物數量和不斷擴張的私人獸醫行業而脫穎而出，而墨西哥則得益於都市區獸醫醫院的發展及其對北美醫療標準的跨境影響。在歐洲，英國、德國、法國、義大利和西班牙擁有成熟的寵物照護體系，注重動物福利、鎮痛安全性和規範用藥，而俄羅斯的需求潛力則受到監管、貨幣和供應鏈複雜性的限制。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠解決術後工作流程中實際挑戰的臨床差異化產品。具體而言，這些產品應具備起效迅速、鎮痛效果持久、劑量針對特定物種、副作用少、配方偏好且易於給藥等特點，並能與多模態治療方案相容。投資於嚴謹的臨床試驗、真實世界數據、藥物警戒和清晰的標籤說明，將有助於提升產品在獸醫、監管機構、經銷商和寵物飼主中的市場地位。

基於證據的市場分析調查方法

本執行摘要基於檢驗的獸醫、監管和行業來源的二手研究，包括動物健康監管機構、獸醫協會、同行評審的臨床文獻、藥物安全監測指南、寵物主人報告、動物福利框架和公共獸醫資訊來源資訊來源。分析重點關注已通過核准的治療分類、臨床護理標準、區域市場促進因素、監管考慮以及推廣應用障礙。

結論：獸醫術後疼痛管理的未來方向

伴侶動物的術後疼痛管理正朝著更實證、技術驅動和以動物福利為中心的模式轉變。這種轉變的驅動力來自外科上的照護、寵物飼主的期望，以及臨床上需要減輕因疼痛管理不當而導致的併發症（例如運動功能恢復延遲、壓力反應、食慾不振、睡眠障礙、傷口狀況不良和恢復期延長）。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 伴侶動物術後疼痛管理治療市場：依藥物類別分類

  • 局部麻醉劑
    • Bupivacaine
    • Lidocaine
  • 非類固醇消炎劑
    • 卡洛芬
    • 德拉考昔
    • 菲洛昔布
    • 美洛昔康
  • 鴉片類藥物
    • Buprenornhine
    • Fentanyl
    • 特拉馬多爾

第8章 伴侶動物術後疼痛管理治療市場：依動物類型分類

  • 貓
  • 狗
  • 馬

第9章 伴侶動物術後疼痛管理治療市場：依給藥途徑分類

  • 注射藥物
  • 口服
  • 外用

第10章 伴侶動物術後疼痛管理治療市場：依手術類型分類

  • 整形外科手術
    • 骨折修復手術
    • 關節手術
    • 韌帶修復手術
  • 軟組織手術
    • 絕育手術
    • 腫瘤切除
    • 腹部手術
  • 牙科手術
    • 拔牙
    • 牙周治療

第11章 伴侶動物術後疼痛管理治療市場：依最終使用者分類

  • 動物醫院
  • 學術獸醫機構
  • 居家醫療

第12章 伴侶動物術後疼痛管理治療市場：依通路分類

  • 網路藥房
  • 物理藥房

第13章 伴侶動物術後疼痛管理治療市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 伴侶動物術後疼痛管理治療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 伴侶動物術後疼痛管理治療市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Ashish Life Science Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Century Pharmaceuticals Ltd.
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Fidelis Animal Health
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Richter Pharma AG
  • SAVA Vet
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • Zomedica Corp
Product Code: MRR-221461476CB6

The Companion Animal Postoperative Pain Management Therapeutics Market is projected to grow by USD 328.45 million at a CAGR of 10.36% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 164.65 million
Estimated Year [2026] USD 186.38 million
Forecast Year [2032] USD 328.45 million
CAGR (%) 10.36%

Companion animal postoperative pain management therapeutics are moving from optional supportive care to a core standard of veterinary medicine. Surgical volumes across sterilization, orthopedics, dentistry, oncology, wound repair, and minimally invasive procedures continue to create sustained demand for safe analgesics, multimodal protocols, and clinic-ready pain assessment tools for dogs, cats, and other companion animals.

The landscape is shaped by evidence-based veterinary guidelines, rising pet humanization, broader pet insurance adoption in developed economies, and regulatory oversight from agencies such as the U.S. FDA Center for Veterinary Medicine, Health Canada, the European Medicines Agency, and national veterinary authorities. Demand is strongest where veterinarians can combine nonsteroidal anti-inflammatory drugs, opioids, local anesthetics, alpha-2 agonists, adjunctive agents, and nonpharmacologic recovery support into individualized, species-specific postoperative pain plans.

Transformative Shifts in the Postoperative Pain Management Landscape

The landscape is shifting toward multimodal analgesia, with veterinarians increasingly combining anti-inflammatory control, regional anesthesia, local anesthetic delivery, and rescue analgesia rather than relying on single-agent therapy. This shift is supported by AAHA, AAFP, WSAVA, and other veterinary bodies that emphasize routine pain scoring, preemptive analgesia, patient warming, comfort-focused handling, and reassessment throughout recovery.

Commercially, clinics are prioritizing therapeutics that improve compliance, reduce dosing errors, and support safe discharge after routine and advanced procedures. Long-acting injectable formulations, species-specific labeling, controlled-substance stewardship, and improved safety monitoring are becoming decisive differentiators. Manufacturers that align clinical evidence with workflow efficiency are positioned to capture value across general practice, specialty hospitals, emergency surgery settings, and home recovery programs.

Cumulative Impact of Artificial Intelligence on Pain Therapeutics

Artificial intelligence is beginning to influence companion animal postoperative pain management through decision support, image and video-based behavioral analysis, remote monitoring, and pharmacovigilance. AI-enabled systems can help detect changes in posture, mobility, appetite, vocalization, sleep, activity levels, and wound interference that may indicate inadequate analgesia after surgery, especially when pets recover at home.

The cumulative impact is not replacement of veterinary judgment, but better triage, earlier intervention, and more consistent documentation. Data-driven pain scoring, predictive adverse-event monitoring, and electronic medical record integration can support safer NSAID selection, opioid stewardship, dose review, and individualized recovery protocols. Adoption will depend on clinical validation, explainability, cybersecurity, interoperability, privacy safeguards, and clinician trust.

Key Regional Insights Across Global Veterinary Pain Therapeutics

North America remains a high-value region due to advanced veterinary infrastructure, strong pet ownership, high surgical caseloads, and reimbursement support from pet insurance. The United States and Canada benefit from established FDA and Health Canada pathways, specialty hospital networks, continuing veterinary education, and widespread use of multimodal analgesia. Latin America is expanding as Brazil and Mexico invest in companion animal care, though affordability, uneven clinic access, and variable distribution infrastructure continue to influence therapeutic uptake.

Europe is driven by stringent welfare standards, EMA-regulated product quality, antimicrobial and controlled-substance stewardship, and high awareness of postoperative pain control across the United Kingdom, Germany, France, Italy, Spain, and neighboring markets. Asia-Pacific is a fast-evolving opportunity as China, India, Japan, South Korea, Australia, and ASEAN economies combine urban pet ownership growth with rising veterinary service sophistication and greater demand for premium companion animal healthcare. The Middle East, led by GCC markets, shows premium clinic development and growing demand for advanced surgical recovery protocols, while Africa remains heterogeneous, with growth concentrated in urban centers where veterinary access, professional training, and pharmaceutical distribution are improving.

Key Group Insights for EU, G7, BRICS, ASEAN, GCC, and NATO Markets

The European Union is a regulatory and clinical benchmark for companion animal postoperative pain management therapeutics because of harmonized medicine oversight, animal welfare policy, pharmacovigilance requirements, and strong veterinary professional standards. G7 markets collectively represent premium veterinary innovation environments, supported by advanced referral hospitals, high disposable income, companion animal insurance awareness, and established veterinary pharmaceutical channels.

BRICS markets are increasingly important for volume expansion and long-term access, particularly as Brazil, China, and India scale companion animal services, urban clinics, and veterinary distribution networks, while Russia and South Africa present more complex access and infrastructure conditions. ASEAN shows rising demand through urbanization and pet ownership in markets such as Indonesia, Thailand, Vietnam, Malaysia, Singapore, and the Philippines. GCC countries are building premium veterinary infrastructure supported by high-income urban pet ownership, while NATO-aligned markets overlap substantially with North American and European demand centers where supply security, controlled-substance compliance, cold-chain resilience, and reliable medical logistics are strategic priorities.

Key Country Insights in Companion Animal Postoperative Pain Care

The United States leads in product availability, specialty care adoption, continuing education, and postoperative pain protocol standardization, while Canada benefits from strong veterinary governance, high companion animal health awareness, and growing pet insurance penetration. Mexico and Brazil are key Latin American growth markets, with Brazil standing out for its large companion animal population and expanding private veterinary sector, and Mexico supported by urban clinic development and cross-border exposure to North American care standards. In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature companion animal care ecosystems with strong attention to welfare, analgesic safety, and regulated medicine use, while Russia presents demand potential tempered by regulatory, currency, and supply-chain complexity.

China and India are major long-term opportunities as pet ownership, urban veterinary clinics, digital pet health engagement, and middle-class spending expand. Japan and South Korea demonstrate high expectations for premium pet healthcare, precise dosing, minimally invasive surgery, and safety-focused therapeutics. Australia is notable for strong veterinary standards, high companion animal ownership, and rapid uptake of evidence-based pain management across general and specialty practices, supported by professional guidance and owner willingness to invest in postoperative recovery quality.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated products that solve real postoperative workflow challenges: rapid onset, durable analgesia, clear species-specific dosing, low adverse-event burden, palatable or easy-to-administer formats, and compatibility with multimodal protocols. Investment in robust clinical trials, real-world evidence, pharmacovigilance, and labeling clarity will strengthen positioning with veterinarians, regulators, distributors, and pet owners.

Organizations should also build education-led commercialization models. Training on validated pain scoring, feline-safe analgesia, renal and hepatic risk screening, NSAID monitoring, opioid stewardship, local anesthetic techniques, and discharge compliance can increase therapeutic adoption. Strategic partnerships with veterinary schools, corporate hospital networks, digital monitoring platforms, diagnostic providers, and pet insurers can improve market access while reinforcing evidence-based standards of care.

Research Methodology for Evidence-Based Market Analysis

This executive summary is developed using secondary research from verified veterinary, regulatory, and industry sources, including animal health regulatory agencies, veterinary medical associations, peer-reviewed clinical literature, pharmacovigilance guidance, pet ownership reports, animal welfare frameworks, and public veterinary health resources. The analysis emphasizes approved therapeutic classes, clinical care standards, regional market drivers, regulatory considerations, and adoption barriers.

Insights are triangulated across supply-side indicators, veterinary practice trends, pet demographics, product labeling, prescribing standards, and regional healthcare infrastructure. The methodology avoids speculative market sizing, market share, and forecasting where current verified data are unavailable and focuses on defensible, evidence-backed interpretation relevant to manufacturers, distributors, veterinary hospitals, investors, insurers, and digital health partners.

Conclusion: Future Direction for Veterinary Postoperative Pain Management

Companion animal postoperative pain management therapeutics are entering a more evidence-driven, technology-enabled, and welfare-focused phase. Demand is supported by rising surgical care standards, pet owner expectations, and the clinical need to reduce complications associated with unmanaged pain, including delayed mobility, stress responses, reduced appetite, sleep disruption, wound interference, and prolonged recovery.

The strongest opportunities will belong to organizations that combine regulatory-quality therapeutics with practitioner education, validated monitoring tools, responsible controlled-substance practices, and regional market access strategies. As veterinary teams continue to adopt multimodal analgesia and objective pain assessment, postoperative pain management will remain a defining pillar of modern companion animal healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Companion Animal Postoperative Pain Management Therapeutics Market, by Drug Class

  • 7.1. Local Anesthetics
    • 7.1.1. Bupivacaine
    • 7.1.2. Lidocaine
  • 7.2. Non-Steroidal Anti-Inflammatory Drugs
    • 7.2.1. Carprofen
    • 7.2.2. Deracoxib
    • 7.2.3. Firocoxib
    • 7.2.4. Meloxicam
  • 7.3. Opioids
    • 7.3.1. Buprenorphine
    • 7.3.2. Fentanyl
    • 7.3.3. Tramadol

8. Companion Animal Postoperative Pain Management Therapeutics Market, by Animal Type

  • 8.1. Cats
  • 8.2. Dogs
  • 8.3. Horses

9. Companion Animal Postoperative Pain Management Therapeutics Market, by Route Of Administration

  • 9.1. Injectable
  • 9.2. Oral
  • 9.3. Topical

10. Companion Animal Postoperative Pain Management Therapeutics Market, by Surgery Type

  • 10.1. Orthopedic Surgery
    • 10.1.1. Fracture Repair
    • 10.1.2. Joint Surgery
    • 10.1.3. Ligament Repair
  • 10.2. Soft Tissue Surgery
    • 10.2.1. Spaying Neutering
    • 10.2.2. Tumor Removal
    • 10.2.3. Abdominal Surgery
  • 10.3. Dental Surgery
    • 10.3.1. Tooth Extraction
    • 10.3.2. Periodontal Procedures

11. Companion Animal Postoperative Pain Management Therapeutics Market, by End User

  • 11.1. Veterinary Hospitals
  • 11.2. Academic Veterinary Institutes
  • 11.3. Home Care Settings

12. Companion Animal Postoperative Pain Management Therapeutics Market, by Distribution Channel

  • 12.1. Online Pharmacies
  • 12.2. Offline Pharmacies

13. Companion Animal Postoperative Pain Management Therapeutics Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Companion Animal Postoperative Pain Management Therapeutics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Companion Animal Postoperative Pain Management Therapeutics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Ashish Life Science Pvt. Ltd.
  • 17.2. Boehringer Ingelheim International GmbH
  • 17.3. Century Pharmaceuticals Ltd.
  • 17.4. Ceva Sante Animale S.A.
  • 17.5. Dechra Pharmaceuticals PLC
  • 17.6. Elanco Animal Health Incorporated
  • 17.7. Fidelis Animal Health
  • 17.8. Indian Immunologicals Limited
  • 17.9. Intas Pharmaceuticals Ltd.
  • 17.10. Merck & Co., Inc.
  • 17.11. Norbrook Laboratories Limited
  • 17.12. Phibro Animal Health Corporation
  • 17.13. Richter Pharma AG
  • 17.14. SAVA Vet
  • 17.15. Vetoquinol S.A.
  • 17.16. Virbac S.A.
  • 17.17. Zoetis Inc.
  • 17.18. Zomedica Corp

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BUPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BUPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIDOCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIDOCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIDOCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARPROFEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARPROFEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARPROFEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DERACOXIB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DERACOXIB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DERACOXIB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FIROCOXIB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FIROCOXIB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FIROCOXIB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MELOXICAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MELOXICAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MELOXICAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BUPRENORPHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUPRENORPHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BUPRENORPHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TRAMADOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRAMADOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRAMADOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FRACTURE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FRACTURE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FRACTURE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL JOINT SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOINT SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL JOINT SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPAYING NEUTERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPAYING NEUTERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPAYING NEUTERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TUMOR REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TUMOR REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TUMOR REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DENTAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DENTAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DENTAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 252. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 262. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 264. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG